Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-043853

Neon Therapeutics, Inc. · NTGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
Period of report
Jun 29, 2018
Accepted (ET)
Jul 3, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001694187

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F4Jun 29, 2018C8,999,999—A9,399,999D
Common StockF3,F2,F4Jun 29, 2018C341,637—A9,741,636D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF2,F4—Jun 29, 2018C45,000,000D——Common Stock8,999,9990D
Series B Preferred StockF2,F4—Jun 29, 2018C1,708,185D——Common Stock341,6370D

Explanation of responses